MerTK + macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation
Science Advances · 04.10.2024 · 10 (40)
DOI: 10.1126/sciadv.ado8366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 04.10.2024. Verfasst von Naming Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China. Hauptthemen laut MEDLINE: c-Mer Tyrosine Kinase, Immunotherapy, Macrophages, Melanoma. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Despite our increasing understanding of macrophage heterogeneity, drivers of macrophage phenotypic and functional polarization in the microenvironment are not fully elucidated. Here, our single-cell RNA sequencing data identify a subpopulation of macrophages expressing high levels of the phagocytic receptor MER proto-oncogene tyrosine kinase (MerTK + macrophages), which is closely associated with melanoma progression and immunotherapy resistance. Adoptive transfer of the MerTK + macrophages into recipient mice notably accelerated tumor growth regardless of macrophage depletion. Mechanistic studies further revealed that ALK And LTK Ligand 1 (ALKAL1), a target gene of aryl hydrocarbon receptor (AhR), facilitated MerTK phosphorylation, resulting in heightened phagocytic activity of MerTK + macrophages and their subsequent polarization toward an immunosuppressive phenotype. Specifically targeted delivery of AhR antagonist to tumor-associated macrophages with mannosylated micelles could suppress MerTK expression and improved the therapeutic efficacy of anti–programmed cell death ligand 1 therapy. Our findings shed light on the regulatory mechanism of MerTK + macrophages and provide strategies for improving the efficacy of melanoma immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.
- Hubei Engineering Research Center for Skin Repair and Theranostics, Wuhan 430022, China.
- Department of Dermatology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.
- Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.
ORCID-Profile: Naming Wu, Jun Li, Lu Li, Enzhu Dong, Juan Tao
Zitieren
APA
Wu, N., Li, J., Li, L., Yang, L., Dong, L., Shen, C., Sha, S., Fu, Y., Dong, E., Zheng, F., Tan, Z., & Tao, J. (2024). MerTK + macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation. Science Advances, 10(40). https://doi.org/10.1126/sciadv.ado8366
Vancouver
Wu N, Li J, Li L, Yang L, Dong L, Shen C, et al. MerTK + macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation. Science Advances. 2024;10(40). doi:10.1126/sciadv.ado8366
BibTeX
@article{Wu2024,
author = {Wu, Naming and Li, Jun and Li, Lu and Yang, Liu and Dong, Liyun and Shen, Chen and Sha, Shanshan and Fu, Yangxue and Dong, Enzhu and Zheng, Fang and Tan, Zheng and Tao, Juan},
title = {MerTK + macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {40},
doi = {10.1126/sciadv.ado8366}
}
EUVIMED